Overview

Defining the Functional and Neuro-Protective Potential of ACTHAR in Acute Optic Neuritis

Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The goal of the study is to determine the earliest structural changes in the optic nerve during the acute event and during the twelve months of recovery following Acthar treatment.
Phase:
Early Phase 1
Details
Lead Sponsor:
Neuro-Ophthalmologic Associates, PC
Collaborator:
Mallinckrodt
Treatments:
Adrenocorticotropic Hormone